ECHO-7

ECHO-7 (trade name Rigvir) is a wild type member of the echovirus group of viruses. It was formerly approved as a virotherapy medication by the State Agency of Medicines of the Republic of Latvia (2004–19). In March 2019, laboratory tests found the medicine to contain far smaller quantities of ECHO-7 virus than its manufacturer claimed. On May 31, 2019, the State Agency of Medicines suspended the registration licence of ECHO-7.